Cardiomyopathy, doxorubicin: See: Doxorubicin cardiomyopathy.
Established doxorubicin cardiomyopathy is a lethal disease. When congestive heart failure develops, mortality is approximately 50%. Extensive research has been done to ...
Doxorubicin cardiomyopathy: Heart disease due to the drug doxorubicin (brand name:Adriamycin), a potent broad-spectrum antitumor agent effective in treating a variety of ...
Despite its vast utility in clinical oncology, the use of doxorubicin hydrochloride (Adriamycin) is limited by a potentially fatal cardiomyopathy.
Doxorubicin-induced cardiomyopathy information including symptoms, diagnosis, misdiagnosis, treatment, causes, patient stories, videos, forums, prevention, and ...
Review Article from The New England Journal of Medicine — Doxorubicin-Induced Cardiomyopathy